TWA
AUPH icon

TCI Wealth Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History

TCI Wealth Advisors’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-250
Closed -$2K – 2503
2022
Q3 		$2K Sell
250
-278
-53% -$2.41K ﹤0.01% 1896
2022
Q2 		$5K Buy
528
+278
+111% +$3.11K ﹤0.01% 1442
2022
Q1 		$3K Hold
250
– – ﹤0.01% 1853
2021
Q4 		$6K Buy
+250
New +$5.92K ﹤0.01% 1498

Other funds holding AUPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

TCI Wealth Advisors's AUPH Position: Q4 2022 in Review

TCI Wealth Advisors sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2022, closing a stake of 250 shares — an estimated $2K sold.

TCI Wealth Advisors first reported a position in AUPH in Q4 2021 and held it in 4 quarters. The position peaked at $6K in Q4 2021. 191 funds tracked by Wall St. Rank hold AUPH as of Q4 2022.

  • TCI Wealth Advisors reported no remaining Aurinia Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • TCI Wealth Advisors sold 250 Aurinia Pharmaceuticals shares in Q4 2022, an estimated $2K.
  • TCI Wealth Advisors first reported a position in Aurinia Pharmaceuticals in Q4 2021 and held it in 4 quarters.
  • TCI Wealth Advisors's Aurinia Pharmaceuticals position peaked at $6K in Q4 2021.
  • 191 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2022.

Based on TCI Wealth Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.